Public health; Oklahoma Rare Disease Advisory Council; purpose; appointment procedures; membership requirem...
Do you support it?
Want to know if it passes?
We'll email you when HB 1019 moves — a committee vote, a floor vote, or a signature. Nothing else.
Free forever · unsubscribe in one click.
Your answer was recorded either way.
Which district are you in?
Your ZIP is all we need to match you to your own representatives — so we can tell you how they voted on HB 1019.
You're tracking HB 1019
We'll email you the moment it moves.
HB 1019 — Public health; Oklahoma Rare Disease Advisory Council; purpose; appointment procedures; membership requirements; annual report; membership terms; vacancies; term; effective date.
Last action — Referred to Appropriations and Budget Health Subcommittee
No card. One bill, free forever — alerts when it moves.
-
✓Introduced
-
2In Committee
-
3Passed House
-
4Passed Senate
-
5To Executive
-
6Enacted
This bill is in committee in the House. Introduced February 03, 2025. It must pass committee before a floor vote.
Next likely step: a committee vote, then a floor vote in the House.
Prognosis
Where this bill stands today.
Odds of enactment
LowHow often bills like it became law.
-
In Committee
Current position in the legislative process.
-
2 sponsors
2 primary, 0 co-sponsors signed on.
-
Single-party support
Sponsorship is currently within one party (2 D).
Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.
Bill Text
What changed in the latest version
160 added · 236 removedPlain-language change summary
The amendments to HB 1019 involve a complete rework of the bill's text, removing the original content and replacing it with a new framework for establishing the Oklahoma Rare Disease Advisory Council. This new version outlines the purpose and activities of the council, emphasizing its role in supporting public health related to rare diseases. The change is significant because it officially sets up a platform for addressing the needs and challenges of individuals affected by rare diseases in Oklahoma, promoting better resources and awareness in this area.
STATEHB1019 OFSUBPCS1 OKLAHOMAMichelle 2McCane-TJ 1st2/13/2025 Session1:57:19 ofpm theCOMMITTEE 60thAMENDMENT LegislatureHOUSE (2025)OF 3REPRESENTATIVES HOUSEState BILLof 1019Oklahoma By:SPEAKER:
McCaneCHAIR: 4 5 AS INTRODUCED 7 An Act relating to public health;
I move to amend HB1019 Of the printed Bill Page Section Lines Of the Engrossed Bill By deleting the content of the entire measure, and by inserting in lieu thereof the following language:
AMEND TITLE TO CONFORM TO AMENDMENTS Amendment submitted by:
Michelle McCane Adopted:
_____________________________ ______________________Reading Clerk___ STATE OF OKLAHOMA 1st Session of the 60th Legislature (2025) PROPOSED SUBCOMMITTEE SUBSTITUTE FOR HOUSE BILL NO.
1019 By:
McCane 6 8 PROPOSED SUBCOMMITTEE SUBSTITUTE An Act relating to public health;
providing for per diem expenses;
TheThere Oklahomais Rarehereby Diseasecreated Advisory Council shall be established within the State Department of Health inthe accordanceOklahoma withRare thisDisease section.Advisory Council.
The purpose of the Council shall be to provide guidance and recommendations to educate the public, the Legislature, and other stateReq. agencies, as appropriate, on the needs of individuals with rare diseases living in this state.
Req.
1109512482 Page 1 C.state agencies, as appropriate, on the needs of individuals with rare diseases living in this state.
TheC. Council shall conduct the following activities to 2 benefit those impacted by rare diseases in this state:
3The 1.Council shall conduct the following activities to benefit those impacted by rare diseases in this state:
Convene1. public hearings, make inquiries, and solicit comments from the general public in Oklahoma to assist the Council 5 with a first-year landscape or survey of the needs of rare disease 6 patients, caregivers, and providers in the state;
7Convene 2.public hearings, make inquiries, and solicit comments from the general public in Oklahoma to assist the Council with a first-year landscape or survey of the needs of rare disease patients, caregivers, and providers in the state;
Provide2. testimony and comments on pending legislation and 8 regulations before the Legislature, if called, and other state agencies that impact Oklahoma's rare disease community;
Provide testimony and comments on pending legislation and regulations before the Legislature, if called, and other state agencies that impact Oklahoma's rare disease community;
Identify areas of unmet need for research and opportunities for collaboration across stakeholders and other state rare disease advisoryReq. councils that can inform future studies and work done by the Council;
and Req.
1109512482 Page 2 6.advisory councils that can inform future studies and work done by the Council;
Research and identify6. best practices to reduce health 2 disparities and achieve health equity in the research, diagnosis, 3 and treatment of rare disease in this state.
Research and identify best practices to reduce health disparities and achieve health equity in the research, diagnosis, and treatment of rare disease in this state.
The Council's appointment process shall be conducted in 5 a transparent manner to provide interested individuals an 6 opportunity to apply for membership on the Council.
All members of 7 the Council shall be full-time residents of this state as 8 practicable.
The ChairGovernor shall appoint noseven fewer(7) thanmembers: seventeen (17) members, including the following:
onetwo representativepatients ofwho anhave academica research institution in the state that receives any grant funding for rare diseasedisease, research, b.
onetwo representativecaregivers of thea Stateperson Departmentwith ofa Health'srare Officedisease, of Minority Health and Health Equity, or successor division, c.
one representative of the Oklahomabiopharmaceutical Healthindustry, Care Authority, d.
one representative of thea Insurancerare Department,disease Req.patient organization that operates in this state, and e.
No.one representative of a health plan company.
110954. Page 3 e.
oneThe registeredState nurseDepartment orof AdvancedHealth Practiceshall Registeredappoint 2five Nurse(5) licensedmembers: and practicing in this state with 3 experience treating rare diseases, f.
one physician practicing in this state with experience 5 treating rare diseases, 6 g.
one geneticist or genetic counselor, 7 h.
one hospital administrator, or his or her designee, 8 from a hospital in this state that provides care to persons diagnosed with a rare disease, i.
at least two patients who have a rare disease, j.
at least one caregiver of a person with a rare disease, k.
one representative of a rare disease patient organization that operates in this state, l.
Show all 80 changed lines (40 more)
one pharmacist with experience dispensing drugs used to treat rare diseases, m.
one representative of the biopharmaceutical industry, n.
one representative of a health plan company, o.
one member of the scientific community who is engaged in rare disease research including, but not limited to, a medical researcher with experience conducting research on rare diseases, and p.
one mental health provider with experience treating rare disease patients in this state.
1109512482 Page 43 E.a.
one representative of the State Department of Health's Office of Minority Health and Health Equity, or successor division, b.
one registered nurse or Advanced Practice Registered Nurse licensed and practicing in this state with experience treating rare diseases, c.
one physician practicing in this state with experience treating rare diseases, d.
one pharmacist with experience dispensing drugs used to treat rare diseases, and e.
one member of the scientific community who is engaged in rare disease research including, but not limited to, a medical researcher with experience conducting research on rare diseases.
5.
The Oklahoma Health Care Authority shall appoint two (2) members:
a.
one representative of the Oklahoma Health Care Authority, and b.
one geneticist or genetic counselor.
6.
The Department of Mental Health and Substance Abuse Services shall appoint one member who is a mental health provider with experience treating rare disease patients in this state.
7.
The State Regents for Higher Education shall appoint one member who is a representative of an academic research institution Req.
No.
12482 Page 4 in the state that receives any grant funding for rare disease research.
E.
The Council shall electronically submit a report to the 2 President Pro Tempore of the Oklahoma State Senate, the Speaker of 3 the Oklahoma House of Representatives, and the Governor within one (1) year of establishment of the Oklahoma Rare Disease Advisory 5 Council and annually thereafter.
Prior to submission, a draft of 6 the annual report shall be made available for public comment and 7 discussed at an open public meeting.
8 2.
G.Req.
No.
12482 Page 5 G.
At the end of the chair's initial three-year Req.term, and every two (2) years thereafter, members of the Council shall elect, by a majority vote, a new chair.
No.2.
11095Council Pagemembers 5shall term,serve andno everylonger twothan (2)three years(3) thereafter,years, membersexcept that, to facilitate a staggered rotation of members to retain continuity and knowledge transfer, during the Councilinitial 2five shall(5) elect,years byafter athe majorityestablishment vote,of the Council, members may serve up to a newfour-year chair.term.
33. 2.
Council members shall serve no longer than three (3) years, except that, to facilitate a staggered rotation of members to retain 5 continuity and knowledge transfer, during the initial five (5) years 6 after the establishment of the Council, members may serve up to a 7 four-year term.
8 3.
As used in this section, "rare disease", sometimesalso calledknown as an orphan disease, means a disease that affects fewer than two hundred thousand (200,000) people in the United States.
I.
The members of the Council shall be paid a per diem in accordance with the State Travel Reimbursement Act when attending Council meetings or other activities associated with the duties of the Council members.
60-1-1109560-1-12482 TJ 12/13/2402/13/25 Req.
1109512482 Page 6
Show all 80 changed rows (40 more)
View plain text versions (2)
- Committee Substitute Proposed Committee Substitute (sub committee) 1 Current pdf
- Introduced View text pdf
Action History
-
Referred to Appropriations and Budget Health Subcommittee
-
Referred to Appropriations and Budget
-
Withdrawn from Rules Committee
-
Referred to Rules
-
Withdrawn from Appropriations and Budget Committee
-
Second Reading referred to Appropriations and Budget
-
Authored by Representative McCane
-
First Reading
Sponsors
- Michelle McCane · Primary
- Carri Hicks · Primary
Sponsorship breakdown
Export CSV (upgrade) →2 sponsors · 0 co-sponsors · 149 not signed on
Sponsors (2)
- Michelle McCane Democrat
- Carri Hicks Democrat
Co-sponsors (0)
None.
Not signed on (149)
149 members have not signed on to this bill.
Show all 149 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Subjects
Frequently asked questions
- Who sponsors HB 1019?
- HB 1019 is sponsored by Michelle McCane (Democrat) and Carri Hicks (Democrat).
- What is the current status of HB 1019?
- This bill is in committee in the House. Introduced February 03, 2025. It must pass committee before a floor vote.
- Where can I track HB 1019?
- Track HB 1019 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on HB 1019
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of HB 1019
Last checked for changes 3 months ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →